Occidental Petroleum: A Deep Value Study

Whether revenue is recurring, stable, and predictable. From the angle of "demand exists," oil and gas are needed for the long term; from the angle of "cash distributable to shareholders," it is far from stable. In 2025, total revenue was about $21.593 billion, below 2024's $22.019 billion and 2023's $23.156 billion, even as production rose from 1.222 million boe/d to 1.328 million and then to 1.434 million. This shows OXY's revenue is not determined by sales volume but by volume × commodity price × differentials; management itself acknowledged in 2025 that oil prices averaged about 14% below 2024. In other words, the "recurrence" of this business comes from reserves and continuous development, not from predictable pricing.

Cost structure and dependencies. The cost structure of oil and gas companies is inherently capital-heavy and capex-heavy. In 2025, OXY's depreciation, depletion, and amortization (DD&A) was about $7.533 billion, net interest expense about $1.079 billion, operating cash flow about $10.532 billion, and total capex about $7.487 billion. On the early-2026 earnings call, management gave a very important "owner's perspective" signal: by their definition, sustaining capital to maintain 1.42 million boe/d of production in 2025 was about $4.5 billion; excluding OxyChem, about $4.2 billion. This means OXY's true economic profit cannot be read from net income alone; you have to look at how much cash is left after maintaining production.

What it depends on. This company does not depend on a few large customers, but it clearly depends on: first, reserve quality and replacement capacity; second, the geology and development efficiency of core basins such as the Permian; third, the regulatory/permitting environment, for example the setback requirements in Colorado's DJ Basin; fourth, capital markets and the balance sheet, because this is a cyclical industry; and fifth, policy support and market formation, especially for carbon management and DAC operations. The company states plainly that the carbon-management market is not yet mature and its commercial viability is uncertain, and that it may fail if the relevant markets and regulatory support are insufficient.

If the stock market closed for 5 years, would I hold it? My answer is: yes, but only at the right price. Bought in a clearly undervalued zone, I would be willing to view OXY as a set of low-cost resource assets plus an ongoing deleveraging story. Bought near fair value, I would not treat it as an easy "close your eyes and hold for five years" choice, because over those five years you still bear oil-price risk, reserve-replacement risk, capex discipline, and uncertain returns from low-carbon projects. This judgment does not negate the company; it acknowledges the reality of the industry.

Industry and Moat

Industry stage and long-term demand. The oil and gas industry is neither simply a growth industry nor a declining one; it is a mature, large industry plus a highly volatile cyclical one. Over the long run, the world still has physical demand for oil and gas; over the short-to-medium term, supply and demand, geopolitics, inventories, and policy will make prices swing sharply. The external environment of 2026 illustrates this especially well: the EIA's May 2026 STEO, hit by geopolitical shocks, briefly expected a sharp inventory tightening in Q2, with Brent staying high in May-June, but it also expected prices to fall in Q4 2026 and 2027 as production recovers; the IEA's May 2026 report cut its 2026 global oil demand forecast to a year-over-year contraction. For a long-term owner, you must not anchor long-term intrinsic value on "today's high oil price."

Competitive landscape. OXY's main comparables are not consumer-goods leaders but upstream strongholds like EOG and ConocoPhillips, along with the larger, more diversified Exxon and Chevron. OXY positions itself as one of the large U.S. oil and gas producers, leading in the Permian and DJ; in 2025 it produced about 10% of all crude in the Permian Basin. For comparison, EOG produced 450 million boe in 2025 with year-end proved reserves of 5.514 billion boe; ConocoPhillips produced about 2.375 million boe/d in 2025, clearly larger in scale. In other words, OXY is not a small company, but it is not an irreplaceable industry hegemon either.

Whether the industry profit pool is concentrated and whether the company has pricing power. This industry's profit pool is determined more by resource quality, position on the cost curve, transportation and processing capacity, and balance-sheet resilience than by end-brand or high switching costs. OXY's marketing and pipeline capacity, its WES stake, and its Permian+EOR combination do improve net realized prices and development economics, but it remains fundamentally a price taker. When oil, gas, and regional differentials are favorable, it looks excellent; when prices are unfavorable, the moat manifests more as "getting hurt less than weaker companies" rather than "not getting hurt at all." So I define it as an excellent asset package in a poor industry, not a "moat king in a good industry."

Moat component judgments. Brand advantage: weak. Selling oil and gas is not a consumer brand battle. Cost advantage: moderate. Permian scale, EOR experience, DJ contiguous acreage, and WES/marketing synergies all help. The company discloses that about 84% of its resource volume has a breakeven below $50/barrel, with an average resource breakeven of about $38/barrel, but this is a management-defined metric, not an audited GAAP one. Scale advantage: moderate. OXY's size and infrastructure in the Permian carry real weight. Network effects: almost none. Switching costs: low. Channel/infrastructure advantage: moderate. Marketing, storage and transport, WES, and the long-term delivery system improve throughput efficiency. Patent/license/regulatory barriers: moderate. Oil and gas development permits, CO2 EOR technology, and cross-regional operating experience form a barrier, but not an impossible one to replicate. Data advantage: limited. It is mostly engineering and geological know-how. Culture/operating capability: moderately strong. In recent years the company has repeatedly emphasized remote operations, AI, efficiency gains, and domestic new wells outperforming the industry. Capital allocation capability: moderate. Clearly improved over the past two years, but with a history shadowed by high-leverage acquisitions.

Is the moat widening, stable, or narrowing? I think it is broadly stable with slight improvement, but not meaningfully wider. The improvement comes from CrownRock deepening the Permian, ongoing cost reductions, WES synergies, and deleveraging after asset sales. It cannot be called wider because OXY still has not escaped its "commodity business" essence. For a competitor to replicate a Permian+upstream capability set close to OXY's would take years and billions of dollars; but replicating "the impact of the oil-price cycle on cash flow" requires no time at all, which is the cruelest reality of this industry.

Inflation, recession, and profit quality. OXY has no real "active pricing power" in an inflationary environment, but rising oil prices themselves lift nominal prices; conversely, service costs, steel, equipment, and labor also push up capex. It is not necessarily highly profitable in a downturn, but management's 2026 guidance shows that under a $40 oil price scenario, the company believes about $4.1 billion of sustaining capital can keep production flat. This shows asset quality is good enough to support survival and maintenance, not that earnings escape unscathed. Past high profits benefited markedly from cyclical tailwinds, especially the 2022 cash-flow peak, and cannot be mechanically extrapolated.

Management and Capital Allocation

Whether management is trustworthy. Vicki Hollub has been CEO since 2016, with more than 40 years inside OXY, a deep résumé and a strong operating background. The company's recent public materials are not flashy in tone, consistently focused on maintaining production, growing the dividend, lowering debt, and optimizing capital intensity, which is a plus in a resource company. The board and executives are also bound by clawback and anti-hedging provisions. On "honesty and long-term orientation," I rate management above average.

But why I don't give a higher score. There are two reasons. First, OXY's modern capital-allocation history carries heavy baggage: to acquire Anadarko, it introduced Berkshire's high-cost preferred stock and subsequent warrants into its capital structure. As of year-end 2025, this preferred still accrued at an 8% coupon, and if not fully paid it compounds at 9%, and it cannot be redeemed at the company's option before August 2029. In 2025 the company paid $679 million in preferred dividends. Second, completing the CrownRock acquisition in 2024 markedly boosted 2025 production but also brought equity and debt pressure, showing OXY still has a tendency to "deepen resource quality through M&A." Whether such decisions truly add value for shareholders cannot be judged by production growth alone.

Shareholder alignment. This is not a typical "management heavily owns its own stock" story. According to the 2026 proxy statement, as of March 10, 2026, directors and executives beneficially owned about 4.9265 million shares in aggregate, against roughly 991.7 million shares outstanding on the same day, a combined stake of only about 0.5%. This means management's alignment with shareholders comes more from compensation structure and tenure reputation than from large personal holdings. For a long-term investor this is not a fatal flaw, but it does cap how high I will rate capital allocation.

How the cash is used. In 2025, OXY's order of cash use was quite clear: maintain capex on one side while using asset sales and operating cash flow to repay debt on the other, all while preserving its dividend-growth commitment. In 2025 the company repaid about $4 billion of debt with asset sales and cash; after year-end, it continued repaying about $5.4 billion of debt with proceeds from the OxyChem transaction, bringing principal debt down to about $15 billion by the time the 2025 annual report was filed, and Q1 2026 results then showed principal debt had fallen to $13.3 billion as of May 5. By contrast, the company executed no share buybacks in 2025, even though $1.2 billion of buyback authorization remained; this instead shows that, before the high-leverage shadow is fully lifted, management prioritized deleveraging over dressing up EPS, which is rational.

How to assess dividends, buybacks, and M&A. On the common dividend, in 2025 the company paid common shareholders about $945 million, or $0.96 per share; in Q1 2026 it raised this to $0.26 per share per quarter. This shows management is indeed delivering on its "sustainable dividend growth" narrative. On buybacks, I endorse the prudence of not repurchasing in 2025, but if the company resumes large-scale buybacks in the future without an adequate margin of safety, I would turn negative. On M&A, the "industrial logic" of CrownRock holds, deeper Permian inventory, higher oil weighting, larger operating scale, but "whether per-share value rose" must be verified over the coming years by unit sustaining capital, unit returns, and Owner Earnings per share, not self-justified by total production growth.

Financial Quality and Owner Earnings

First, let me look at the financial cross-sections I consider most important. Because OxyChem was already divested in early 2026, 2025 and Q1 2026 are a "transition-period basis": historical comparability carries noise, so the table below gives both GAAP figures and an explanation of each.

How to read the past 5-7 year trend. Stretching the cycle out makes the financial picture clearer: in 2019 the company had net sales of about $20.911 billion and operating cash flow of $7.375 billion; in 2020, hit by the pandemic and asset impairments, net sales were about $17.809 billion, operating cash flow fell to $3.955 billion, and equity dropped to $18.573 billion; in 2021 operating cash flow recovered to $10.434 billion; in 2022 it surged further to $16.810 billion; then 2023-2025 entered a high-level pullback while still generating relatively strong cash. In short, OXY's cash flow is not linear growth but a classic cyclical step-up and pullback.

Whether profit is real cash. On the whole, I judge OXY's profit to be closer to "cash profit obscured by accounting volatility" than "accounting profit dressed up." The evidence: 2025 net income was only $2.369 billion, but DD&A was as high as $7.533 billion, operating cash flow was $10.532 billion, and the company's operating cash flow before working capital reached $11.571 billion. This shows that depletion, impairment, taxes, and discontinued-operations reclassifications make GAAP profit unsuitable as the sole anchor; the cash-flow basis is closer to economic reality.

Whether growth requires heavy capital. Yes. OXY is not a capital-light software company but one that "must keep drilling, developing, and maintaining facilities to hold or grow production." Management put this bluntly on the 2026 call: 2026 total capex guidance is about $5.7 billion at the midpoint, of which, after excluding low-carbon and exploration and then mid-cycle projects, so-called sustaining capital is about $4.1 billion (defined at $40 oil). In 2025, sustaining capital to maintain 1.42 million boe/d, excluding OxyChem, was about $4.2 billion. This means OXY can generate distributable cash flow, but only after "continually meeting sustaining capital."

Leverage, debt service, and survivability. As of year-end 2025, total debt and finance leases were about $22.396 billion; by Q1 2026 this fell to $15.671 billion, while cash rose to $3.811 billion. Using an approximate 2025 EBITDA for a rough calculation, year-end 2025 net debt/EBITDA was around 1.7x; on the Q1 2026 basis it clearly declined to roughly 1x. Adding the company's $4.15 billion revolving credit facility, this is no longer the "survival above all else" state of 2020. The question is not "can it survive" but "whether future capital will again be swallowed by expensive acquisitions or low-return projects."

Working capital and accounting quality. One point worth noting in Q1 2026: trade receivables rose from $2.575 billion at year-end 2025 to $3.677 billion, dragging continuing-operations OCF down to $1.392 billion; the company explains this mainly resulted from the rapid rise in oil prices in March 2026 pushing up receivables. This looks more like a cycle and settlement-timing effect than a bad-debt problem, since the company simultaneously discloses that its allowance for doubtful accounts is not significant. Inventory rose from $1.823 billion to $1.862 billion, and a net decrease in payables and accrued liabilities also consumed cash. The conclusion here: short-term cash flow is easily "distorted" by working capital, so I weight the OCF-before-WC basis more heavily.

Whether there are signs of fraud or aggressive accounting. In the 10-K, 10-Q, and proxy statement I reviewed this time, I saw no obvious aggressive revenue recognition or receivables-inflation-type anomalies; but such businesses inherently rely on reserve estimates, development plans, asset impairments, ARO, and carbon-project assumptions, so "no obvious red flags" does not mean "small errors." The company itself stresses that reserve estimates carry inherent imprecision, and that prices, development plans, and regulatory changes can all affect reserves and depletion. For OXY, the biggest accounting risk is not fabricated revenue but estimating resource value and sustaining capital too optimistically.

Owner Earnings estimate. I adopt a conservative method close to Buffett's "owner earnings": focusing on 2025 continuing operations, I take net income of about $2.107 billion (continuing operations), add back DD&A of $7.533 billion, subtract sustaining capital of about $4.2 billion (management's basis, excluding OxyChem), and then subtract continuing-operations working-capital absorption of about $1.067 billion. This yields conservative Owner Earnings of about $4.37 billion. If I normalize working capital over the medium term rather than treating all of 2025's absorption as a permanent norm, a more reasonable Owner Earnings range is roughly $4.5 billion to $5 billion. On about 990 million to 1 billion shares, conservative Owner Earnings are about $4.3 to $4.5 per share.

A one-sentence verdict on Owner Earnings. OXY is not a company with "great-looking net income," but it is indeed a business that generates real cash in a mid-to-high oil-price environment and is currently directing more cash toward deleveraging rather than blind buybacks. The only issue is: this real cash flow is not smooth, and it lacks the high certainty you get from consumer or software leaders.

Valuation and Margin of Safety

The conclusion first. I divide OXY's valuation into three tiers: Conservative intrinsic value range: $42-48/share. Fair intrinsic value range: $52-62/share. Optimistic intrinsic value range: $72-84/share. At the current price of about $57.84, OXY broadly sits "in the upper middle of the fair range": not expensive for an optimist, but not cheap for a conservative either.

Owner-earnings discount method. My three scenario assumptions are as follows. Conservative scenario: starting from $4.3 billion of Owner Earnings, with almost no growth over the next 10 years, a 10% discount rate, and 0% terminal growth; this corresponds to equity value of roughly $42-45 billion, or about $42-45/share. Neutral scenario: starting from $4.5-4.8 billion of Owner Earnings, with average annual growth of 2% over the next 10 years, a discount rate of 9.5%-10%, and 1.5% terminal growth; this corresponds to roughly $52-62 billion, or about $52-62/share. Optimistic scenario: starting from $5 billion of Owner Earnings, with average annual growth of 4% over the next 10 years, a 9% discount rate, and 2% terminal growth; this corresponds to roughly $72-84 billion, or about $72-84/share. The most fragile assumption here is not the discount rate but whether "mid-cycle oil prices + sustaining capital + reserve quality" can keep Owner Earnings above $4.5 billion.

Relative valuation method. Based on current market data, OXY's market cap and trailing P/E are about $57.15 billion and 14.5x; EOG about $72.94 billion and 13.4x; ConocoPhillips about $139.62 billion and 19.8x; Exxon about $436.67 billion and 25.2x; Chevron about $253.61 billion and 32.2x. On trailing P/E alone, OXY is clearly below COP, XOM, and CVX, and close to EOG. But this does not directly prove OXY is cheap, because OXY's business is more concentrated in the upstream, with earnings volatility and capital requirements higher than the more diversified integrated majors.

From the other metrics I roughly calculate using the latest balance sheet: With Q1 2026 total debt and finance leases of $15.671 billion and cash of $3.811 billion, current enterprise value is about $69 billion; against year-end 2025 proved reserves of 4.603 billion boe, EV/proved reserves is about $15/boe; against Q1 2026 total equity of $39.56 billion, P/B is about 1.44x; against my conservatively estimated Owner Earnings of $4.37 billion, P/OE is about 13x. All these metrics indicate: it is not a cheap residual-value stock, but it has not reached an absurd overvaluation either.

Asset or liquidation value method. The "book value" of a resource business has limited reference value, but it is not meaningless either. OXY's Q1 2026 total equity was about $39.56 billion, clearly below the current market cap; yet this does not mean it is necessarily expensive, because the economic value of oil and gas reserves, infrastructure, the WES stake, and Permian inventory is often higher than book net value. At the same time, liquidation value is dragged down by asset retirement obligations (ARO, about $4.128 billion) and reserve price sensitivity. My conclusion: the asset method can only give you a boundary of "probably not a severe bubble," not a reliable upper limit. What truly determines value is still mid-cycle cash flow.

Ideal buy, hold, and clearly overvalued ranges. My desired ideal buy range is $42-48: this roughly amounts to a 20%-30% discount to fair value, enough to compensate for industry cyclical risk. The acceptable hold range I see is $48-62: provided you already understand you are holding a cash-cow resource stock, not a moat-driven consumer stock. The clearly overvalued range I see is roughly above $70: that would mean the market has already priced in, to a large degree, higher oil prices, continued cost reduction, and low-carbon project realization. Therefore, the current price is closer to a "hold/watch price" than an "ideal new-buy price."

Margin-of-safety judgment. For a company like OXY, the margin of safety I require should be higher than for a consumer leader, because it has no brand pricing power and no network effects. If future growth comes in below expectations, margins decline, and the valuation multiple contracts, you may still earn a decent long-term return, but only if the entry price is low enough. At the current price, I do not see sufficient "room to be wrong." So my clear conclusion is: the margin of safety is inadequate, and it is worth waiting for a better price.

Risks, Comparisons, Checklist, and Final Conclusion

The most important risks. First, cyclical risk: OXY's cash flow is highly sensitive to oil prices and regional differentials, and the 2026 energy market has already been distorted by geopolitical shocks; both the EIA and IEA warn against mechanically extrapolating today's high prices. Second, financial leverage risk: although principal debt has fallen quickly to $13.3 billion, the expensive preferred stock and remaining leverage will still amplify shareholder drawdowns in a downcycle. Third, asset quality and sustaining-capital risk: if future sustaining capital is clearly higher than management's current basis, it means the judgment on inventory quality or operating efficiency was too optimistic. Fourth, low-carbon project return risk: if projects like STRATOS fall short on regulatory support, tax credits, or commercialization speed, they may keep consuming capital. Fifth, regulatory and geopolitical risk: Colorado permitting requirements, international PSC contracts, and uncertainty in North Africa and the Middle East will all affect production and collections.

The strongest bear case. The strongest short thesis is not "oil prices will fall tomorrow" but: OXY may simply be a capital-intensive business that looks cheap in a high-oil-price environment but actually has no real moat. If oil prices revert to mid-low levels over the next 5-10 years, U.S. shale inventory quality declines and pushes up sustaining capital, and the low-carbon business stays unprofitable, then the 4 to 5 billion dollars of Owner Earnings you see today may be only a "good-year illusion." Add the preferred stock, the legacy warrants, and the M&A impulse, and the per-share intrinsic-value increment common shareholders capture may not be significant. This bear case is not absurd; I think it must be taken seriously.

Which facts would overturn the investment judgment. If the following facts appear, I would admit the original judgment was wrong and reassess or even exit: First, principal debt stops falling, or rises clearly again, and not for high-certainty, strong-return projects; Second, the $4.1-4.2 billion sustaining capital management cites is persistently proven too low by reality; Third, reserve replacement falls clearly below 100% for several consecutive years, and not because of deliberate high-price asset disposals; Fourth, low-carbon/carbon-management projects still show no outline approaching management's stated $90 million to $130 million of EBITDA around 2028; Fifth, a renewed capital-allocation tendency toward high-debt large M&A over per-share value, like the past.

Comparison with other opportunities. Versus EOG: I prefer EOG's "pure upstream + strong culture + cleaner balance sheet + higher shareholder-return discipline." EOG's 2025 free cash flow was about $4.7 billion, ROCE about 19%, and it claims to return 100% of free cash flow to shareholders; its trailing P/E is close to OXY's, but its capital story is cleaner. Versus ConocoPhillips: COP is larger in scale, more diversified in portfolio, with thicker total equity and more mature net-debt management. Versus SPY: SPY currently trades around $750.59 and represents immediate whole-market diversification, whereas OXY requires you to take on additional commodity, geopolitical, and capital-allocation assumptions. For a balanced, slightly conservative investor, OXY only clearly outperforms simply buying the index when it trades at a clear discount.

Whether it beats the risk-free rate or high-grade bonds. I am not willing to give a precise bond-comparison figure here without a full reconstruction; but on investment logic, as an equity asset concentrated in the upstream commodity cycle, OXY should offer a long-term expected return clearly above U.S. Treasuries and high-grade bonds to merit allocation. Under my current valuation assumptions, at the present price OXY can offer only a roughly mid-single-digit to low-double-digit scenario-based long-term return, not high enough to "clearly beat" the risk-free alternative. So it is not, in my mind, a high-certainty core position that "must be included even if you could only hold 5 assets."

Investment Checklist

[Final Rating] Watch

[One-Sentence Investment Thesis] OXY is a U.S. resource company with decent asset quality and clear deleveraging progress, but it remains a highly cyclical business with a limited moat and high sensitivity to the buy price.

[Core Bull Case] OXY holds a sizable, operable, and re-developable resource base in the Permian, DJ, Gulf of America, and the Middle East and North Africa, with 2025 proved reserves of about 4.603 billion boe, and the Permian remains an important low-cost core. The company's capital-allocation priorities have been healthier over the past two years: deleverage first, then pay dividends, then opportunistic buybacks; by Q1 2026 principal debt had fallen to $13.3 billion. In 2025 the company's free cash flow before working capital reached $4.284 billion and CROCE reached 19%, showing its cash-return capacity is not weak. Management discloses that about 84% of resource volume has a breakeven below $50/barrel, with an average resource breakeven of about $38/barrel, indicating some support for asset quality and full-cycle economics. The WES stake, marketing, and CO2 EOR capabilities give OXY better throughput and cost-reduction synergies than a typical pure-upstream company.

[Core Bear Case] OXY is fundamentally still a commodity price taker, lacking brand, network effects, and high-switching-cost-style moats. The high GAAP profit in Q1 2026 was markedly inflated by the OxyChem discontinued-operations gain and does not represent recurring earnings power. The expensive preferred stock and legacy warrants continue to erode the per-share intrinsic-value elasticity of common shareholders. Business growth requires continuous heavy capital investment, and Owner Earnings are highly sensitive to "whether the sustaining-capital basis is real." The current price lacks a sufficient margin of safety and is not cheap enough for a balanced, slightly conservative investor.

[Key Assumptions] Medium-to-long-term oil prices do not see a deep, sustained drop below the economics of OXY's core assets. Sustaining capital can broadly be kept near management's current stated basis of about $4.1-4.2 billion. Debt continues to fall rather than being swallowed by new high-price M&A. Low-carbon capex gradually declines, and STRATOS shows verifiable operating returns by around 2028 at the latest.

[Fair Buy Price] $42-48/share. The basis: a 20%-30% discount to my conservative Owner Earnings discounted value and fair intrinsic value range, used to hedge the risks of the commodity cycle, capital intensity, and management misjudgment.

[Target Holding Period] At least 5-10 years, and you must accept riding through at least one full oil-price cycle within that span. Not suitable for short-term capital.

[Expected Annualized Return] Conservative scenario: 2%-4%. Neutral scenario: 7%-9%. Optimistic scenario: 11%-13%. These returns rest on different Owner Earnings paths and the speed of valuation convergence, and should not be read too precisely.

[Maximum Loss Risk] If oil prices fall markedly and stay low for the long term over the coming years, sustaining capital rises, low-carbon project returns disappoint, and management re-levers to expand, OXY could see a permanent capital loss of more than 40% from the current price; in an extreme cycle, the market may also anchor its price to a lower conservative intrinsic value. This risk is not theoretical but a real attribute of resource stocks.

[Tracking Metrics] Key items to track: Continuing-operations OCF and OCF before working capital; Sustaining capital and total capex; Principal debt balance and progress on the preferred stock; Permian production, single-well performance, and unit development cost; Proved reserves and reserve replacement; Common dividend growth and whether large buybacks restart; STRATOS/carbon-management project capex and EBITDA realization pace; WES contribution and marketing differentials; Basic/diluted share-count changes; Mid-cycle oil prices and regional differentials.

[Signals Triggering Reassessment] Deleveraging stalls or reverses; Sustaining capital is clearly higher than the current basis; Insufficient reserve replacement for several consecutive years; Low-carbon projects keep burning large amounts of cash with no operating inflection; Restarting large-scale buybacks or high-price M&A in the absence of clear undervaluation; Regulatory or operational deterioration in international projects and key regions like Colorado.

[Final Recommendation] For an investor with "10 years or more, balanced and slightly conservative," I would not make OXY a high-priority new buy at the current price. It is worth studying and worth placing on a watch list; if the share price returns to a range closer to $42-48 in the future, or if the company continues deleveraging and proves with facts that sustaining capital really is lower and more sustainable, then it would move from a "comprehensible cyclical asset" closer to a "value target worth acting on." Until then, I lean toward viewing it as a company you can hold, but need not rush to buy, rather than an opportunity you must board immediately.

Open Questions and Limitations This report has tried to prioritize the company's 2025 annual report, Q1 2026 10-Q/earnings materials, and authoritative public data, but two limitations must be made explicit: first, I did not fully reconstruct an engineer-grade NAV/PV-10 for each basin in this memo, so the asset method is a rough estimate rather than a full reserve model; second, the early-2026 OxyChem divestiture causes a switch between the historical basis and the future basis, so any annualization of the future using 2025 data should be handled conservatively.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.